NO991717L - Truncated platelet activating factor acetyl hydrolase - Google Patents

Truncated platelet activating factor acetyl hydrolase

Info

Publication number
NO991717L
NO991717L NO991717A NO991717A NO991717L NO 991717 L NO991717 L NO 991717L NO 991717 A NO991717 A NO 991717A NO 991717 A NO991717 A NO 991717A NO 991717 L NO991717 L NO 991717L
Authority
NO
Norway
Prior art keywords
activating factor
platelet activating
acetyl hydrolase
factor acetyl
truncated
Prior art date
Application number
NO991717A
Other languages
Norwegian (no)
Other versions
NO326968B1 (en
NO991717D0 (en
Inventor
Lawrence S Cousens
Christine D Eberhardt
Patrick Gray
Hai Le Trong
Larry W Tjoelker
Cheryl L Wilder
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Priority to NO19991717A priority Critical patent/NO326968B1/en
Publication of NO991717D0 publication Critical patent/NO991717D0/en
Publication of NO991717L publication Critical patent/NO991717L/en
Publication of NO326968B1 publication Critical patent/NO326968B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01047—1-Alkyl-2-acetylglycerophosphocholine esterase (3.1.1.47), i.e. platelet-activating factor acetylhydrolase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19991717A 1997-08-13 1999-04-12 PAF-AH polypeptide fragment, isolated polynucleotide, DNA vector, host cell, process for producing a PAF-AH polypeptide fragment, variant or variant fragment of plasma PAF-AH, PAF-AH polypeptide fragment, variant or variant fragment, pharmaceutical composition, use of the PAF-AH fragment, variant or variant fragment for the preparation of a medicament for treating a mammal. NO326968B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19991717A NO326968B1 (en) 1997-08-13 1999-04-12 PAF-AH polypeptide fragment, isolated polynucleotide, DNA vector, host cell, process for producing a PAF-AH polypeptide fragment, variant or variant fragment of plasma PAF-AH, PAF-AH polypeptide fragment, variant or variant fragment, pharmaceutical composition, use of the PAF-AH fragment, variant or variant fragment for the preparation of a medicament for treating a mammal.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1997/014212 WO1999009147A1 (en) 1997-08-13 1997-08-13 Truncated platelet-activating factor acetylhydrolase
NO19991717A NO326968B1 (en) 1997-08-13 1999-04-12 PAF-AH polypeptide fragment, isolated polynucleotide, DNA vector, host cell, process for producing a PAF-AH polypeptide fragment, variant or variant fragment of plasma PAF-AH, PAF-AH polypeptide fragment, variant or variant fragment, pharmaceutical composition, use of the PAF-AH fragment, variant or variant fragment for the preparation of a medicament for treating a mammal.

Publications (3)

Publication Number Publication Date
NO991717D0 NO991717D0 (en) 1999-04-12
NO991717L true NO991717L (en) 1999-06-11
NO326968B1 NO326968B1 (en) 2009-03-23

Family

ID=22261441

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991717A NO326968B1 (en) 1997-08-13 1999-04-12 PAF-AH polypeptide fragment, isolated polynucleotide, DNA vector, host cell, process for producing a PAF-AH polypeptide fragment, variant or variant fragment of plasma PAF-AH, PAF-AH polypeptide fragment, variant or variant fragment, pharmaceutical composition, use of the PAF-AH fragment, variant or variant fragment for the preparation of a medicament for treating a mammal.

Country Status (12)

Country Link
EP (1) EP0948605A1 (en)
JP (1) JP2001502163A (en)
AU (1) AU751594B2 (en)
BR (1) BR9711882A (en)
CA (1) CA2267994C (en)
CZ (1) CZ297603B6 (en)
HU (1) HUP9903959A3 (en)
IL (3) IL129262A0 (en)
NO (1) NO326968B1 (en)
PL (1) PL190532B1 (en)
SK (1) SK286518B6 (en)
WO (1) WO1999009147A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981252A (en) 1993-06-25 1999-11-09 Smithkline Beecham Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
EP1294943A2 (en) * 2000-01-20 2003-03-26 Genome Therapeutics Corporation RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE
CN103891709A (en) * 2012-12-24 2014-07-02 深圳先进技术研究院 Cell cryopreservation liquid and cell cryopreservation method
WO2022120784A1 (en) * 2020-12-11 2022-06-16 深圳上泰生物工程有限公司 Composition and application thereof in detecting activity of lipoprotein-related phospholipase a2
CN112575057B (en) * 2020-12-11 2021-07-30 深圳上泰生物工程有限公司 Composition and application thereof in detecting activity of lipoprotein-associated phospholipase A2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981252A (en) * 1993-06-25 1999-11-09 Smithkline Beecham Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
JP3613398B2 (en) * 1993-10-06 2005-01-26 イコス コーポレイション Platelet activating factor acetylhydrolase
WO1997012984A1 (en) * 1995-09-29 1997-04-10 Smithkline Beecham Plc COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE
EP0859834A2 (en) * 1995-09-29 1998-08-26 Smithkline Beecham Plc A paf-acetylhydrolase and use in therapy

Also Published As

Publication number Publication date
CZ124199A3 (en) 2000-06-14
AU3978297A (en) 1999-03-08
EP0948605A1 (en) 1999-10-13
WO1999009147A1 (en) 1999-02-25
PL332833A1 (en) 1999-10-11
HUP9903959A2 (en) 2000-03-28
SK286518B6 (en) 2008-12-05
NO326968B1 (en) 2009-03-23
HUP9903959A3 (en) 2002-01-28
IL129262A (en) 2006-06-11
JP2001502163A (en) 2001-02-20
NO991717D0 (en) 1999-04-12
CZ297603B6 (en) 2007-02-07
IL129262A0 (en) 2000-02-17
IL173867A0 (en) 2006-07-05
SK47399A3 (en) 2000-11-07
AU751594B2 (en) 2002-08-22
BR9711882A (en) 1999-09-21
CA2267994C (en) 2005-04-12
PL190532B1 (en) 2005-12-30
CA2267994A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
DE69801596T2 (en) esterification
DE69805538T2 (en) DISTRIBUTED VIRTUAL ENVIRONMENT
DE69832623D1 (en) MICRO-MADE CIRCLES
DE69839157D1 (en) FULLURENE KATHERDERSYSTEM CONTAINING
ID24314A (en) PLACE TO PLACE FAST-APPROXIMATELY
DE69808855T2 (en) adhesive
DK94897A (en) Propeller
DE69802424T2 (en) EXHIBITION TANKS
DE69811489T2 (en) CARBON-SILICON COMPOSITE
DE59809001D1 (en) TRANSDUCER
DE59810709D1 (en) Transducer System
DE69818003D1 (en) CONNECTION STRUCTURE
DE69810444D1 (en) POLARIZATION-RESISTING FIBER-OPTICAL ASSEMBLY
NO991717L (en) Truncated platelet activating factor acetyl hydrolase
DE59804489D1 (en) dowel
DE59808611D1 (en) dowel
DE69817539D1 (en) PC CHIPANORDNUNGVERBINDUNGSBUS
DE69840513D1 (en) SOUND SYSTEM
ATE238786T1 (en) ANTI-FIRST-PASS EFFECT SUBSTANCES
ID20897A (en) MEETING-CLOSING STRUCTURE
PT862024E (en) DEHUMIDIFIER
KR970021033U (en) Dehumidifier
FR2767567B3 (en) PROPELLER
DE69708044T2 (en) structural member
LV11965A (en) Propolis Adhesive

Legal Events

Date Code Title Description
MK1K Patent expired